Key words: alcoholic chronic pancreatitis, idiopathic juvenile early onset chronic pancreatitis, idiopathic senile late onset chronic pancreatitis Chronic pancreatitis (CP) is a progressive infl ammatory process, which usually evolves over years into pancreatic cirrhosis, irrespective of endoscopic or surgical interventions, except autoimmune pancreatitis (reversed by steroids) or obstructive pancreatitis (relieved by removal of obstruction). The latter two conditions are not considered here, particularly because the typical progressive evolution of CP is lacking.
course from onset to late-stage CP: clinical features, morphology, and function. Clinical features and function are closely interrelated variables and change in association with progressive acinar destruction and fi brosis from disease onset to late-stage CP.
Early-stage CP usually starts with recurrent acute pancreatitis. The diagnostic criteria of acute pancreatitis are well established. The broad overlap of clinical features in acute pancreatitis irrespective of etiology, in particular between gallstone and alcoholic pancreatitis, the two most prominent causes of acute pancreatitis in industrialized countries (60%-80%), renders a precise differentiation between acute and chronic pancreatitis virtually impossible at onset. Many experts, therefore, prefer to label initial episodes of acute pancreatitis according to etiology, for example, as alcoholic or gallstone pancreatitis.
Alcohol abuse is a prominent risk factor for both acute and chronic pancreatitis. The debate on classifi cation of CP has been confounded during the past 40 years by the dogma of Marseille, which postulates that (1) acute pancreatitis and CP are two distinct nosological entities and (2) acute pancreatitis virtually never progresses to CP. In fact, gallstone pancreatitis rarely progresses to CP. 1 In contrast, most experts currently agree that alcoholic and hereditary CP are the end result of repeated episodes of acute pancreatitis, that is, the necrosis-fi brosis hypothesis of CP by Klöppel and Maillet. 2 Basically, there are three major challenges in the diagnosis of early-stage CP: (1) pancreatic histology, which is the gold standard of early-stage CP, is rarely available; (2) clinical, functional, and morphological features are identical at onset in both acute reversible (e.g., gallstone) and progressive (alcoholic) pancreatitis; and (3) a time lag, averaging 4.5-5.5 years, exists between acute onset pancreatitis and documentation of markers of advanced alcoholic CP. [3] [4] [5] Time lag between acute onset pancreatitis and defi nite (advanced) CP Monitoring of pancreatic function is important for differentiating acute reversible and chronic progressive pancreatitis in the early stages of disease if pancreatic histology is not available. For instance, the fecal chymotrypsin profi le over a period of more than 10 years from disease onset is documented in a series of acute (gallstone) pancreatitis attacks (n = 74) versus alcoholic CP (n = 114) (Fig. 2) . Obviously, the fecal chymotrypsin profi le remained normal (>120 µg/g) in acute pancreatitis for >10 years. In contrast, the fecal chymotrypsin profi le became progressively pathological in CP. However, the fi rst defi nitely low values occurred 3 years after onset. In other words, there was a typical time lag-a diagnostic "black-box" period-between disease onset and the development of markers of advanced late-stage CP. [3] [4] [5] Thus, a defi nite categorization of pancreatitis in its initial stages is often impossible because of this time lag. The following case reports illustrate the problem in a few patients with acute onset pancreatitis.
Case 1. 60-year-old woman
This patient had biliary acute pancreatitis combined with obstructive cholestasis due to choledocholithiasis. She initially showed mild pancreatic insuffi ciency, as proven by a pathological pancreozymin-secretin test (P/S-Test) and low fecal chymotrypsin values (FCT) over an 8-month period after disease onset (Fig. 3) . Some experts would probably conclude that the patient has CP. However, the patient was followed-up for 21 months. At 10 months, a second P/S-Test was normal, and the FCT profi le normalized by 21 months after disease onset. Thus, the fi nal interpretation of case 1 was acute biliary pancreatitis with transient (reversible) pancreatic insuffi ciency.
Case 2. 41-year-old man
The patient had a fi rst severe episode of acute alcoholic pancreatitis in 1974. In 1975, a second mild attack followed. Thereafter, the patient remained asymptomatic despite continuation of alcohol consumption in moderate amounts. Yearly control studies documented no evidence of exocrine insuffi ciency for 12 years after disease onset, with constantly high-normal FCT values This female patient developed exocrine insuffi ciency following acute gallstone pancreatitis (fecal chymotrypsin concentration <120 µg/g; P/S-Test) that lasted 8 months from onset, suggesting chronic pancreatitis. However, the P/S test results were normal at 10 months, and the fecal chymotrypsin level was normal at 21 months after disease onset, indicating that the exocrine insuffi ciency was reversible and that progression to CP is unlikely in this patient (Fig. 4) . Some experts would probably exclude CP in this patient. However, 13 years after onset, the FCT values suddenly dropped to very low levels and calcification was documented for the fi rst time. Thus, the fi nal interpretation in case 2 was alcoholic CP, diagnosed after a time lag of 13 years after disease onset.
Case 3. 34-year-old man
This alcoholic patient had four episodes of acute pancreatitis within 1 year from onset. The FCT profi le normalized at 1.5 years after onset and remained normal until 8 years after onset, probably owing to cessation of alcohol Fig. 4 . Case 2. Long-term disease evolution in a patient with severe acute alcoholic pancreatitis in 1974, followed by a second mild pancreatitis attack in 1975. Thereafter, the patient remained asymptomatic despite continued reduced alcohol intake (i.e., the pain probably stopped because of the alcohol reduction). No evidence of exocrine insuffi ciency was found at yearly control studies for 12 years after onset. After this time lag, the fecal chymotrypsin values suddenly dropped, calcifi cation was noted, and diabetes (controlled by oral antidiabetics) developed at 20 years after onset Fig. 5 . Case 3. Long-term disease evolution following four episodes of acute alcoholic pancreatitis within 1 year. Exocrine insuffi ciency ( path) was documented by the fi rst P/S-Test (PST), and low fecal chymotrypsin values reverted to normal 1.5 years after onset, probably due to cessation of alcohol intake. At 7 years after onset, pancreatitis recurred, and persistent exocrine insuffi ciency developed following a time lag of 8 years after onset, in association with pancreatic calcifi cation (Calcif.) at 10 years after onset. Despite continued alcohol abuse, no further episodes of pancreatitis occurred in the last 4 years of life (burn-out of late-stage CP; see text below). D-Op, Drainage operation abuse (Fig. 5) . Some experts would probably conclude that progression to CP is unlikely in this patient. However, between 7 and 8 years after onset, pancreatitis recurred: a pancreatic pseudocyst developed, which was treated by a surgical drainage procedure. Exocrine insuffi ciency developed at 8 years after onset (low FCT, pathological P/S-Test). Calcifi cation was documented at 10 years after onset. Thus, the fi nal interpretation in case 3 was alcoholic chronic pancreatitis, fi rst documented after a time lag of 9 years after onset of disease.
Preliminary conclusions
1. In patients with fi rst onset pancreatitis, categorization as acute versus chronic pancreatitis is rarely possible without histology. 2. Prolonged surveillance of patients is necessary to prove or exclude CP because of the delay in development of markers of CP (time lag).
3. It is likely that a large percentage of patients classifi ed as having acute alcoholic pancreatitis will progress to CP if followed up for years.
Rate of progression of CP
The rate of progression to alcoholic late-stage CP from disease onset varies considerably (Table 1) , but the reasons for this variable rate are unknown. There is, however, evidence that cessation or a reduction of alcohol abuse may delay the progression to advanced CP. 8 Moreover, smoking appears to accelerate the progression to calcifi cation, as shown by a recent international multicenter study 9 (Fig. 6 ). Etiology is an additional factor that impacts the progression rate of CP (see below).
There are only limited data on the relationship between morphology and function in the course of the disease from onset to late-stage CP. Our group studied this Fig. 6 . Rate of progression to pancreatic calcifi cation is signifi cantly increased by smoking in alcoholic CP 9 issue in 73 alcoholic CP patients using either surgical or necropsy specimens. Surgical and necropsy specimens were available in 10 of 73 patients (Figs. 7 and 8 ). 10 The median fi brosis score (FS, on a scale of 0-12) increased from 6.2 within 4 years of onset to 10.2 at ≥13 years after onset. Calcifi cation (%) increased almost threefold between onset and ≥13 years after onset, closely matching the increase in fi brosis (Fig. 7) .
Exocrine insuffi ciency (fecal chymotrypsin <120 mg/ g) was closely correlated with the fi brosis score and was noted in 87%-97% of patients with a fi brosis score of 7 to 12 (Fig. 8) . Diabetes was observed in about 60% of patients with a fi brosis score of ≥10 but in only about 15% of those with a fi brosis score of ≤9.
These fi ndings indicate that repeated function testing is a rather reliable surrogate for histology for monitoring the progression of CP. Moreover, the data support the notion that advanced late-stage CP can be diagnosed reliably by most available routine methods if adequate histological specimens are not available.
By applying strict criteria, a diagnosis of CP has been confi rmed at our center over the last 40 years in a total of 343 patients. 7 At the same time, an equal number of patients (n = 385) with suspected but unproven CP (socalled probable CP) were excluded because histology or data indicating progression to late-stage CP were lacking.
Impact of etiology on the rate of progression of CP
Knowledge of the natural history of CP, which is the backbone of CP diagnosis, is still limited. For instance, only a few previous prospective studies have investigated the long-term evolution of alcoholic versus nonalcoholic CP separately. 7 At present, the assumption prevails that the natural history of CP is identical irrespective of etiology.
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Diagnosis of advanced CP may be delayed by many years in patients with slow CP progression, as shown above. Interestingly, the progression rate is particularly delayed in patients with nonalcoholic CP, as shown by our group 7 and by a Mayo Clinic series. 6 Idiopathic juvenile "early onset" CP (IJCP), idiopathic senile "late onset" CP (ISCP), and hereditary CP (HP) are three major distinct nosological entities of nonalcoholic CP that differ with respect to age at onset, clinical features 6, 7, 9, 10 (Table 2) , and presence of gene mutation. 12, 13 The fi nal pathway of alcoholic and nonalcoholic CP is almost identical at late stages, as documented by the high incidence of calcifi cation and exocrine insuffi ciency (Table 2) .
Etiology has a major impact on the progression rate of CP. In particular, early-stage CP lasts significantly longer in IJCP and HP than in alcoholic CP (ACP). 7 The development of exocrine insuffi ciency after disease onset is signifi cantly delayed in IJCP and HP versus ACP (Fig. 9) . Documentation of calcifi cation is also markedly delayed after disease onset in HP and IJCP versus ACP (without reaching significance) (Fig. 10) . In ISCP, constituting a large proportion of primary painless CP (i.e., unknown onset), Fig. 8 . Relationship between the fi brosis score and pancreatic dysfunction (see Fig. 7 ). Exocrine insuffi ciency was noted in 87% -97% of patients with a fi brosis score of 7-12. Diabetes was noted in about 60% of patients with a fi brosis score of ≥10 but in only 13% of those with a fi brosis score of ≤9 (modifi ed data from reference 10) pancreatic insuffi ciency or pancreatic calcifi cation were present in up to 70% of patients at the time of diagnosis of CP. The development of diabetes differed also signifi cantly in HP and IJCP compared with ACP (Fig. 11) . In ISCP, diabetes was present in 50% of patients with primary painless CP at diagnosis. Obviously, our series is small and additional prospective long-term studies of mixed medical-surgical CP series are required to corroborate our fi ndings on the impact of etiology on the long-term evolution of CP. On the other hand, our data are in agreement with the results of the Mayo Clinic series (except for HP, which was not considered in that series) 6 and with data of a large European multicenter study of HP. 14 Of special interest in this regard is the debated issue of the relationship between exocrine insuffi ciency and the pain profi le in CP. 7, 15 According to the experience of our group and others, 7, 16, 17 lasting pain relief occurs in uncomplicated late-stage CP in association with progressive exocrine insuffi ciency-burn-out of CP-both in alcoholic and nonalcoholic CP. Because of the delay in the progression, the precalcifi c painful early stage lasts considerably longer in IJCP and HP than in ACP. 7 This observation emphasizes the importance of staging CP, which depends largely on function testing, a currently often-dismissed issue in CP diagnosis and therapy. [15] [16] [17] [18] This controversy, which has yet to be settled, is beyond the scope of the present review. Fig. 9 . The cumulative rate of exocrine insuffi ciency is signifi cantly delayed after onset in nonalcoholic CP, that is, hereditary (HP) and idiopathic juvenile (IJCP) CP, compared with alcoholic CP (ACP) (Kaplan-Meier method). In idiopathic senile CP (ISCP) without pain (about 50% of patients with ISCP), exocrine insuffi ciency was observed at onset/diagnosis in 70% of cases (modifi ed data from reference 7)
Conclusions
1. CP is a dynamic long-term evolving process, which may be divided chronologically into two stages: early-stage and late-stage CP. 2. Late-stage CP can be diagnosed reliably by the markers of CP: calcifi cation, marked ductal changes, and progressive exocrine (endocrine) insuffi ciency. The diagnostic criteria are identical for both alcoholic and nonalcoholic late-stage CP. 3. Clinically, early-stage CP is characterized by recurrent acute pancreatitis, except in primary painless CP-a condition rare in alcoholic but frequent in nonalcoholic CP, particularly ISCP (50%).
4. The diagnostic gold standard of early-stage CP is histology (rarely available). 5. Acute gallstone pancreatitis, in contrast to ACP, usually does not progress to CP. 6. A time lag, averaging 4.5-5.5 years, occurs between acute onset alcoholic pancreatitis and documentation of late-stage CP. 7. The rate of progression from early-to late-stage CP varies considerably for several not clearly defi ned reasons, perhaps in relation to continued alcohol abuse and smoking. 8. Etiology has a major impact on the progression rate of CP; i.e. marked delay in development of exocrine insuffi ciency and calcifi cation after disease onset in Fig. 10 . Probability of remaining free of calcifi cation after onset (see Fig. 9 ). Calcifi cation developed with a marked delay after onset in HP and IJCP compared with ACP; the 50% calcifi cation rate in ACP/ISCP was 3 to 7 years after onset compared with 11 to 14 years in HP/IJCP (no statistical difference) (modifi ed data from reference 7) Fig. 11 . Probability of remaining free of diabetes from onset (see Fig. 9 ). Differences were statistically signifi cant between HP/IJCP and ACP/ISCP. In primary painless ISCP, 12 patients (50%) had diabetes at onset/diagnosis (modifi ed data from reference 7)
HP and IJCP compared to ACP. Therefore, diagnosis of CP may be markedly delayed in nonalcoholic compared with alcoholic CP. 9. A precise defi nition of etiologically different types (i.e., classifi cation) and of different stages of pancreatitis (i.e., staging) is necessary for an improved understanding among experts. At present, terms such as acute and chronic pancreatitis are used with different meanings by different authors.
